Combination PI3K and NOS targeted therapy for metaplastic breast cancer

被引：0
|
作者：
Reddy, T. [1 ]
Rosato, R. [1 ]
Guzman, L. [1 ]
Qian, W. [1 ]
Zhou, J. [1 ]
Piwnica-Worms, H. [2 ]
Moulder, S. [3 ]
Chang, J. [1 ]
机构：
[1] Houston Methodist Res Inst, Ctr Canc, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Canc Biol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Breast Oncol, Houston, TX 77030 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2020年 / 138卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
179
引用
收藏
页码：S49 / S50
页数：2
相关论文
共 50 条
  • [1] Combination PI3K and NOS targeted therapy for metaplastic breast cancer
    Reddy, Tejaswini Parlapalle
    Rosato, Roberto R.
    Guzman, Liliana
    Qian, Wei
    Zhou, Jianying
    Wang, Hongbin
    Piwnica-Worms, Helen
    Moulder, Stacy
    Chang, Jenny C.
    CANCER RESEARCH, 2021, 81 (04)
  • [2] NOS inhibition sensitizes metaplastic breast cancer to PI3K inhibition and taxane therapy via c-JUN repression
    Reddy, Tejaswini
    Puri, Akshjot
    Guzman-Rojas, Liliana
    Thomas, Christoforos
    Qian, Wei
    Zhou, Jianying
    Zhao, Hong
    Mahboubi, Bijan
    Oo, Adrian
    Cho, Young-Jae
    Kim, Baek
    Thaiparambil, Jose
    Rosato, Roberto
    Martinez, Karina Ortega
    Chervo, Maria Florencia
    Ayerbe, Camila
    Giese, Noah
    Wink, David
    Lockett, Stephen
    Wong, Stephen
    Chang, Jeffrey
    Krishnamurthy, Savitri
    Yam, Clinton
    Moulder, Stacy
    Piwnica-Worms, Helen
    Meric-Bernstam, Funda
    Chang, Jenny
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [3] PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
    Zhu, Kunrui
    Wu, Yanqi
    He, Ping
    Fan, Yu
    Zhong, Xiaorong
    Zheng, Hong
    Luo, Ting
    CELLS, 2022, 11 (16)
  • [4] Combined PI3K and NOS inhibition enhances efficacy of taxane-based chemotherapy in metaplastic breast cancer
    Reddy, Tejaswini P.
    Mahboubi, Bijan
    Rosato, Roberto R.
    Guzman-Rojas, Liliana
    Qian, Wei
    Zhou, Jianying
    Kim, Baek
    Moulder, Stacy
    Piwnica-Worms, Helen
    Chang, Jenny C.
    CANCER RESEARCH, 2022, 82 (04)
  • [5] PI3K Inhibitors in Breast Cancer Therapy
    Ellis, Haley
    Ma, Cynthia X.
    CURRENT ONCOLOGY REPORTS, 2019, 21 (12)
  • [6] PI3K Inhibitors in Breast Cancer Therapy
    Haley Ellis
    Cynthia X. Ma
    Current Oncology Reports, 2019, 21
  • [7] Targeting PI3K Signaling in Combination Cancer Therapy
    Pons-Tostivint, Elvire
    Thibault, Benoit
    Guillermet-Guibert, Julie
    TRENDS IN CANCER, 2017, 3 (06): : 454 - 469
  • [8] Tumor mutational analysis and therapy outcomes for patients (pts) with metastatic/unresectable locally advanced myoepithelial/metaplastic breast cancer treated with PI3K targeted therapy
    Moulder, S.
    Wheler, J.
    Albarracin, C.
    Gilcrease, M.
    Falchook, G.
    Naing, A.
    Hong, D.
    Fu, S.
    Piha-Paul, S.
    Tsimberidou, A.
    Janku, F.
    Kurzrock, R.
    CANCER RESEARCH, 2012, 72
  • [9] NOS inhibition augments PI3K inhibitor-induced DNA damage and mesenchymal-to-epithelial transition in metaplastic breast cancer
    Reddy, Tejaswini P.
    Puri, Akshjot
    Guzman-Rojas, Liliana
    Mahboubi, Bijan
    Qian, Wei
    Zhou, Jianying
    Kim, Baek
    Moulder, Stacy
    Piwnica-Worms, Helen
    Rosato, Roberto
    Chang, Jenny C.
    CANCER RESEARCH, 2022, 82 (12)
  • [10] Novel Approaches for Molecular Targeted Therapy of Breast Cancer: Interfering with PI3K/AKT/mTOR Signaling
    Grunt, Thomas W.
    Mariani, Gabriella L.
    CURRENT CANCER DRUG TARGETS, 2013, 13 (02) : 188 - 204
12345